All company sites ABOUT COMPANY PRESS CENTER DIRECTIONS PRODUCTS INVESTORS subscribe to news Subscribe / Unsubscribe news Press releases Press about us Presentations News of the world market of investments in biotech Biotech library Press Kit: Key Facts, HSCI Brochure Contacts Print RSS Feeds Feedback History of the company HSCI Group structure Shareholder structure Pipeline Financial statements NEWS 20.09.2018 Vascular surgeons voted for gene therapy On September 14, 2018, at the international conference "Prospects for the development of vascular surgery in the country and its regions", the results of a large-scale interactive voting showed that vascular surgeons consider gene therapy to be a promising and popular method of treating ischemia. 08/29/2018 HSCI Consolidated Results for 1H 2018 under IFRS HSCI PJSC announces its consolidated results of operations for the 1st half of 2018 (6 months ended June 30, 2018) in accordance with International Financial Reporting Standards (IFRS). 07/18/2018 The results of a 5-year use of gene therapy for the treatment of ischemia are published in an international journal In July 2018, the journal Therapeutic Advances in Cardiovascular Disease published an article by Russian experts on the results of a 5-year study of the effectiveness of ischemia treatment with gene therapy. 17.07.2018 Genetico Laboratory became the Shared Use Center of the Skolkovo Foundation The Genetico Center for Genetics and Reproductive Medicine has been accredited by the Skolkovo Foundation as a Shared Use Center (CCU). 05/30/2018 The management of the Company decided to temporarily suspend the daily preparation and publication of financial statements in accordance with IFRS As part of the strategy to optimize costs, the management of the Company made a decision to terminate the quarterly preparation and publication of interim consolidated financial statements in accordance with IFRS. 24.05.2018 Skolkovo began to develop cellular products for the treatment of butterfly children The Skinzel company, a developer of innovative drugs for the treatment of hereditary skin diseases, received the status of a Skolkovo resident in the Biomedical Technologies cluster. 05/23/2018 Scientists have learned to predict the risks of developing dementia According to the WHO, dementia (acquired dementia) develops in 10 million people every year. As the global population ages, the number of people living with dementia will rise to 152 million by 2050. 05/11/2018 Invitation to the online conference on the financial and operational results of PJSC "HSCI" for 2017 under IFRS 05/08/2018 Wasted ovarian syndrome can be treated with umbilical cord stem cells In the spring of 2018, Chinese scientists presented the results of a clinical study on the use of umbilical cord stem cells for the treatment of ovarian wasting syndrome. 05/03/2018 HSCI Consolidated Results for 2017 under IFRS PJSC "HSCI" announces the consolidated results of operations for 2017 in accordance with international financial reporting standards (IFRS), audited by LLC "ReKa-Audit" «Back one23fourfive6789ten... Forward" All years 2018 year 2017 year 2016 year 2015 year year 2014 year 2013 year 2012 2011 2010 year year 2009 2008 year Disclaimer List of insider information © 2003-2018 Human Stem Cell Institute Information disclosure of PJSC "HSCI" on the website of LLC "Interfax-TsRKI"